BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28282403)

  • 1. Chemokine binding protein 'M3' limits atherosclerosis in apolipoprotein E-/- mice.
    Ravindran D; Ridiandries A; Vanags LZ; Henriquez R; Cartland S; Tan JT; Bursill CA
    PLoS One; 2017; 12(3):e0173224. PubMed ID: 28282403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo.
    Bursill CA; Castro ML; Beattie DT; Nakhla S; van der Vorst E; Heather AK; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1773-8. PubMed ID: 20702809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-spectrum chemokine inhibition blocks inflammation-induced angiogenesis, but preserves ischemia-driven angiogenesis.
    Ravindran D; Cartland SP; Bursill CA; Kavurma MM
    FASEB J; 2019 Dec; 33(12):13423-13434. PubMed ID: 31574232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice.
    Bursill CA; Choudhury RP; Ali Z; Greaves DR; Channon KM
    Circulation; 2004 Oct; 110(16):2460-6. PubMed ID: 15477414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
    Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
    Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopoietin-1 promotes atherosclerosis by increasing the proportion of circulating Gr1+ monocytes.
    Fujisawa T; Wang K; Niu XL; Egginton S; Ahmad S; Hewett P; Kontos CD; Ahmed A
    Cardiovasc Res; 2017 Jan; 113(1):81-89. PubMed ID: 28069704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
    Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
    Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of Four-and-a-Half LIM Domain Protein 2 Decreases Atherosclerosis in ApoE-/- Mice.
    Ebrahimian T; Simon D; Lemarié CA; Simeone S; Heidari M; Mann KK; Wassmann S; Lehoux S
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1190-7. PubMed ID: 25767273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice.
    Poupel L; Boissonnas A; Hermand P; Dorgham K; Guyon E; Auvynet C; Charles FS; Lesnik P; Deterre P; Combadiere C
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2297-305. PubMed ID: 23887641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression.
    Zhang H; Guo C; Wu D; Zhang A; Gu T; Wang L; Wang C
    PLoS One; 2012; 7(7):e41147. PubMed ID: 22815945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic analysis reveals the critical role of chemokine signaling in the anti-atherosclerosis effect of Xuefu Zhuyu decoction.
    Jia D; Zhao M; Zhang X; Cheng X; Wei Q; Lou L; Zhao Y; Jin Q; Chen M; Zhang D
    J Ethnopharmacol; 2024 Oct; 332():118245. PubMed ID: 38679399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.
    Karshovska E; Zhao Z; Blanchet X; Schmitt MM; Bidzhekov K; Soehnlein O; von Hundelshausen P; Mattheij NJ; Cosemans JM; Megens RT; Koeppel TA; Schober A; Hackeng TM; Weber C; Koenen RR
    Circ Res; 2015 Feb; 116(4):587-99. PubMed ID: 25472975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
    Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinigrin attenuates the progression of atherosclerosis in ApoE
    Jang YJ; Park B; Lee HW; Park HJ; Koo HJ; Kim BO; Sohn EH; Um SH; Pyo S
    Chem Biol Interact; 2017 Jun; 272():28-36. PubMed ID: 28483571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice.
    Ali ZA; Bursill CA; Hu Y; Choudhury RP; Xu Q; Greaves DR; Channon KM
    Circulation; 2005 Aug; 112(9 Suppl):I235-41. PubMed ID: 16159823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice.
    Dol F; Martin G; Staels B; Mares AM; Cazaubon C; Nisato D; Bidouard JP; Janiak P; Schaeffer P; Herbert JM
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):395-405. PubMed ID: 11486244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice.
    Braunersreuther V; Zernecke A; Arnaud C; Liehn EA; Steffens S; Shagdarsuren E; Bidzhekov K; Burger F; Pelli G; Luckow B; Mach F; Weber C
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):373-9. PubMed ID: 17138939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide inhibitor of NF-κB translocation ameliorates experimental atherosclerosis.
    Mallavia B; Recio C; Oguiza A; Ortiz-Muñoz G; Lazaro I; Lopez-Parra V; Lopez-Franco O; Schindler S; Depping R; Egido J; Gomez-Guerrero C
    Am J Pathol; 2013 May; 182(5):1910-21. PubMed ID: 23597852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.